Companies / Retrotope
Retrotope
United States
Retrotope is developing a pipeline of proprietary therapeutics designed to treat degenerative disease by down-regulating lipid peroxidation in order to protect against cellular degeneration.
Retrotope, based in United States, has 1 investor on file, among them Global Source Ventures. Its site was last checked 6 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Global Source Ventures
9 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (75%), Industrial & Manufacturing (13%), Other (13%).
See Global Source Ventures' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Retrotope and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Global Source Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/retrotope.com/investors
# also
GET /v1/companies/retrotope.com
GET /v1/companies/retrotope.com/news